Antituberculosis Therapy-Associated Cutaneous Leukocytoclastic Vasculitis

descriptionPublicationkeyboard_double_arrow_right Article 18 Jun 2013 English Publisher:Oxford University Press (OUP)Journal:Journal of Tropical Pediatrics, volume 59, pages 507-508 (issn: 0142-6338, eissn: 1465-3664,

Copyright policy )

Authors: Vidyut, Bhatia; Anupam, Sibal; Shilpy, Rajgarhia;

doi: 10.1093/tropej/fmt048

pmid: 23780994

Antituberculosis Therapy-Associated Cutaneous Leukocytoclastic Vasculitis

- Summary
- Subjects
- Metrics

Abstract

Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampicin and pyrazinamide. A 14-year-old male diagnosed with disseminated tuberculosis developed purpuric lesions after 1.5 months of treatment. Histopathology was consistent with leukocytoclastic vasculitis. Skin lesion improved after cessation of the two drugs and treatment with corticosteroids.

Related Organizations

Indraprastha Apollo Hospitals
India

Keywords

Male, Treatment Outcome, Adolescent, Prednisolone, Antitubercular Agents, Humans, Tuberculosis, Vasculitis, Leukocytoclastic, Cutaneous, Rifampin, Pyrazinamide

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average